Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicament composition for treating gouty arthritis

A technology for gouty arthritis and a composition, applied in the field of medicine, can solve problems such as unsatisfactory curative effect and obvious side effects, and achieve the effects of improving medication compliance, definite curative effect and high cure rate

Inactive Publication Date: 2015-01-28
邹士东
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many drugs and preparation methods for treating gouty arthritis have been published in the prior art, such as colchicine and glucocorticoids. These drugs have a certain effect on relieving symptoms, but the final curative effect is not satisfactory, and the side effects are obvious. , many patients will relapse soon

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament composition for treating gouty arthritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Take each raw material of the present invention by the following parts by weight: 8 parts of Cortex Phellodendri, 15 parts of Gentiana chinensis, 10 parts of Smilax smilax, 13 parts of Xugufeng, 15 parts of Mori twig, 20 parts of Xu Changqing, 7 parts of bellflower, 3 parts of ginger, 8 parts of schisandra , 10 parts of Achyranthes bidentata, 16 parts of Panax notoginseng, 8 parts of kudzu root.

Embodiment 2

[0028] Take each raw material of the present invention by the following parts by weight: 5 parts of Cortex Phellodendri, 10 parts of Gentiana chinensis, 5 parts of Smilax smilax, 5 parts of Xugufeng, 10 parts of Mori twig, 15 parts of Xu Changqing, 5 parts of bellflower, 1 part of ginger, 5 parts of schisandra , 5 parts of Achyranthes bidentata, 12 parts of Panax notoginseng, 6 parts of kudzu root.

Embodiment 3

[0030] Take each raw material of the present invention by following parts by weight: 10 parts of Cortex Phellodendri, 20 parts of Gentiana chinensis, 15 parts of Smilax smilax, 20 parts of Xugufeng, 20 parts of Mori twig, 25 parts of Xu Changqing, 10 parts of Platycodon grandiflorum, 6 parts of ginger, 10 parts of Schisandra chinensis , 15 parts of Achyranthes bidentata, 20 parts of Panax notoginseng, 9 parts of kudzu root.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a medicament composition for treating gouty arthritis. The medicament composition comprises the following components of cortex phellodendri, gentiana macrophylla, rhizoma smilacis glabrae, berba aristolochiae mollissimae, ramulus mori, cynanchum paniculatum, platycodon grandiflorum, raw gingers, fructus schizandrae, achyranthes bidentata, panax notoginseng and puerarin. The medicament composition has an extremely good treating effect of treating the gouty arthritis and has small toxic and side effects and high clinical popularization value.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating gouty arthritis. Background technique [0002] Gouty arthritis (Gouty arthritis, GA) is a metabolic bone joint disease caused by the increase of blood uric acid concentration caused by purine metabolism disorder, so that urate crystals are deposited in the joints. Sodium urate (monsodium urate, MSU) crystals have been confirmed as a non-microbial pathogen of GA, and the immune inflammation induced by it plays an important role in the pathogenesis of GA. [0003] Gouty arthritis is a metabolic disease characterized by acute and chronic joint inflammation, mainly manifested as redness, swelling, heat pain, dysfunction of the affected joints, hyperuricemia, tophi, and kidney lesions. The occurrence of gouty arthritis is both primary and secondary. The primary is generally caused by congenital abnormal purine metabolism, rather ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P19/02A61P19/06
CPCA61K36/756A61K9/2826A61K36/21A61K36/258A61K36/264A61K36/27A61K36/34A61K36/488A61K36/51A61K36/57A61K36/605A61K36/79A61K36/896A61K36/90A61K36/9068A61K2236/331A61K2236/51A61K2300/00
Inventor 邹士东
Owner 邹士东
PatSnap Eureka logo

PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.

X (Twitter)LinkedInYouTubeSubstack

© 2026 PatSnap. All rights reserved. 

Terms of Service

 | 

Privacy policy

 | 

Modern Slavery Act Transparency Statement